Sitara Peroxide Statistics
Total Valuation
Sitara Peroxide has a market cap or net worth of PKR 4.52 billion. The enterprise value is 5.01 billion.
| Market Cap | 4.52B |
| Enterprise Value | 5.01B |
Important Dates
The next estimated earnings date is Sunday, February 22, 2026.
| Earnings Date | Feb 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sitara Peroxide has 55.10 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 55.10M |
| Shares Outstanding | 55.10M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 60.65% |
| Owned by Institutions (%) | n/a |
| Float | 17.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.57 |
| P/TBV Ratio | 4.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 230.21 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -22.50 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31, with a Debt / Equity ratio of 0.49.
| Current Ratio | 0.31 |
| Quick Ratio | 0.05 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -67.48 |
Financial Efficiency
Return on equity (ROE) is -20.22% and return on invested capital (ROIC) is -12.46%.
| Return on Equity (ROE) | -20.22% |
| Return on Assets (ROA) | -6.83% |
| Return on Invested Capital (ROIC) | -12.46% |
| Return on Capital Employed (ROCE) | -25.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -14.83M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -88.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +522.44% in the last 52 weeks. The beta is 0.50, so Sitara Peroxide's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +522.44% |
| 50-Day Moving Average | 28.98 |
| 200-Day Moving Average | 18.59 |
| Relative Strength Index (RSI) | 95.50 |
| Average Volume (20 Days) | 545,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -319.52M |
| Pretax Income | -311.35M |
| Net Income | -222.52M |
| EBITDA | -139.26M |
| EBIT | -319.52M |
| Earnings Per Share (EPS) | -4.04 |
Balance Sheet
The company has 5.66 million in cash and 489.25 million in debt, giving a net cash position of -483.59 million or -8.78 per share.
| Cash & Cash Equivalents | 5.66M |
| Total Debt | 489.25M |
| Net Cash | -483.59M |
| Net Cash Per Share | -8.78 |
| Equity (Book Value) | 989.06M |
| Book Value Per Share | 18.00 |
| Working Capital | -1.06B |
Cash Flow
| Operating Cash Flow | 19.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sitara Peroxide does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.04% |
| Earnings Yield | -4.92% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |